# MICAFUNGIN SODIUM
> **ANDA216438** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2024-05-29
## Drug
- **FDA Application Number:** ANDA216438
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MICAFUNGIN SODIUM
- **Generic name:** MICAFUNGIN
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** BIOCON PHARMA
- **Manufacturer:** Biocon Pharma Inc.
- **First approval:** 2024-05-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216438)
---
*AI Analytics · CC0 1.0*